Dental Care Clinics in Forked River, NJ Accepting Medicare
7 Dental Care Clinics found. Showing 1 - 7
 Gentle Dental Providers Llc Dentist Medicare: Not Enrolled in Medicare Practice Location: 1044 Lacey Rd, Forked River, NJ 08731 Phone: 609-994-3880 Fax: 609-242-8668 |
Shannon Keyes Dmd Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 34 Manchester Ave, Suite 204, Forked River, NJ 08731 Phone: 609-971-7900 Fax: 609-971-7799 |
All About Smiles Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 615 Lacey Rd, Suite 5, Forked River, NJ 08731 Phone: 609-242-3567 Fax: 609-242-3330 |
Orthodontics @ Forked River Dentist - Orthodontics and Dentofacial Orthopedics Medicare: Not Enrolled in Medicare Practice Location: 620 West Lacey Road. Suite 6, Forked River, NJ 08731 Phone: 609-693-0117 Fax: 609-693-7555 |
Gentle Dental - Forked River Dentist Medicare: Not Enrolled in Medicare Practice Location: 1044 Lacey Rd Ste 12, Forked River, NJ 08731 Phone: 609-994-3880 |
Best Impressions Dental Clinic/Center - Dental Medicare: Medicare Enrolled Practice Location: 321 Lacey Rd, Forked River, NJ 08731 Phone: 609-693-9166 |
Eastern Dental Of Lacey, Llc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 131 S Main St, Forked River, NJ 08731 Phone: 609-693-6066 |
News Archive
Artificial intelligence-based tool can predict COVID-19 outbreaks at football events
Recent outbreaks of COVID-19 have been detected following football events in the United States, and games have the potential to become "superspreader" events.
Penn researchers find evidence of new culprit in colon cancer
Colon cancer is a heavily studied disease - and for good reason. It is one of the leading causes of cancer-related deaths worldwide, and its numbers are on the rise, from 500,00 deaths in 1990 to 700,000 in 2010.
Nephros granted rights to market products based on Medica's Medisulfone ultrafiltration technology
Nephros, Inc., a medical device company developing and marketing filtration products for therapeutic applications, infection control, and advanced water purification solutions, today announced that the company has entered into a strategic license and supply agreement with Medica S.p.A.
Inhibitor compounds could form basis of new treatments for such diseases as MRSA, anthrax
​Inhibitor compounds developed by UC Irvine structural biologists and Northwestern University chemists have been shown to bolster the ability of antibiotics to treat deadly bacterial diseases such as MRSA and anthrax.
GenSpera expands G-202 Phase I safety trial to CTRC at University of Texas Health Science Center
GenSpera, Inc. announced its intention to expand its Phase I safety trial to study G-202 in relapsed, refractory cancer patients to the Cancer Therapy and Research Center (CTRC) at The University of Texas Health Science Center at San Antonio in San Antonio, TX. The expansion is dependent upon a successful review of the clinical protocol by the Health Science Center Institutional Review Board (IRB). The company anticipates admitting the first patient at this site in the first quarter of 2011.
› Verified 6 days ago